{"schema_version":"alpha-profile-public-v1","slug":"william-rieflin","canonical_url":"https://registry.alpha.ac/people/william-rieflin","as_of":"2026-09-21T20:03:39.131558+00:00","published_at":"2026-09-02T02:37:25.162508+00:00","last_reviewed_at":"2026-05-01T03:00:48.763+00:00","identity":{"display_name":"William Rieflin","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","board"],"current_role":{"company_name":"Lyell Immunopharma, Inc.","company_slug":"lyell-immunopharma-inc","exchange":"NASDAQ","ticker":"LYEL","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","effective_date":"2026-04-24","last_checked_at":"2026-04-24T23:31:00.497+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=william-rieflin","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=william-rieflin&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Mr. Rieflin served as CEO of NGM Biopharmaceuticals from 2010 to 2018 and subsequently as Executive Chairman and Chairman of the Board. He has extensive board experience across multiple pharmaceutical companies including Anacor Pharmaceuticals, RAPT Therapeutics, and XenoPort. He currently serves on the boards of Kallyope, Inc. and Lycia Therapeutics, Inc."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Lyell Immunopharma, Inc.","organizationId":"lyell-immunopharma-inc","title":"Director","period":"2020-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Lyell Immunopharma, Inc.","company_slug":"lyell-immunopharma-inc","exchange":"NASDAQ","ticker":"LYEL","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2020-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","effective_date":"2026-04-24","last_checked_at":"2026-04-24T23:31:00.497+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for William Rieflin as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:48.979749+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:48.851868+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_membership","claim_value":{"ticker":"LYEL","role_type":"Director","organization":"Lyell Immunopharma, Inc."},"claim_text":"Serves on the board of Lyell Immunopharma, Inc. as Director.","claim_state":"verified","valid_from":"2020-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:43.163614+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Lyell Immunopharma, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"William Rieflin currently serves as Director at Lyell Immunopharma, Inc..","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:48.937755+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:48.851868+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit","Compensation"],"claim_text":"William Rieflin serves on Audit, Compensation.","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:48.958141+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:48.851868+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":{"committees":["Audit","Compensation"]},"claim_text":"Committee assignments at Lyell Immunopharma, Inc.: Audit, Compensation.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:43.163614+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Lyell Immunopharma, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for William Rieflin as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:49.029658+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:48.851868+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"director_since","claim_value":{"start_date":null,"director_since":2020},"claim_text":"Director tenure at Lyell Immunopharma, Inc. begins from 2020.","claim_state":"verified","valid_from":"2020-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:43.163614+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Lyell Immunopharma, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"independence_status","claim_value":{"is_independent":true},"claim_text":"Board independence status at Lyell Immunopharma, Inc.: True.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:43.163614+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Lyell Immunopharma, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for William Rieflin as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T03:00:49.000539+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"LYEL DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T03:00:48.851868+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:william-rieflin","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2020-01-01 · current","organization":"Lyell Immunopharma, Inc.","organization_id":"lyell-immunopharma-inc"},"claim_text":"Director at Lyell Immunopharma, Inc. (2020-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/william-rieflin#profile","url":"https://registry.alpha.ac/people/william-rieflin","dateModified":"2026-05-01T03:00:48.763+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/william-rieflin#person","name":"William Rieflin","url":"https://registry.alpha.ac/people/william-rieflin","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Lyell Immunopharma, Inc.","tickerSymbol":"NASDAQ: LYEL"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2020-01-01","memberOf":{"@type":"Organization","name":"Lyell Immunopharma, Inc.","url":"https://registry.alpha.ac/companies/lyell-immunopharma-inc","tickerSymbol":"NASDAQ: LYEL"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1806952/000114036126016686/ny20068007x1_def14a.htm","name":"LYEL DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/william-rieflin"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":8,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":8,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":1,"sources":4,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-01T03:00:48.763+00:00","observed_at":"2026-09-21T20:03:39.131558+00:00","freshness_days":144}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"william-rieflin","canonical_url":"https://registry.alpha.ac/people/william-rieflin"},"publication":{"published_at":"2026-09-02T02:37:25.162508+00:00","last_reviewed_at":"2026-05-01T03:00:48.763+00:00","as_of":"2026-09-21T20:03:39.131558+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/william-rieflin","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/william-rieflin","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/william-rieflin.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}